Chaping Cheng
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
-
- Prostate Cancer Treatment and Research
Papers in
-
- Prostate Cancer Treatment and Research 10
- Ferroptosis and cancer prognosis 2
-
- Immune cells in cancer 2
- Co-authors
- Wei‐Qiang Gao (10 shared papers)Helen He Zhu (10 shared papers)Zhongzhong Ji (8 shared papers)Xue Wang (6 shared papers)Huifang Zhao (7 shared papers)Yanjing Guo (3 shared papers)Li Li (3 shared papers)Yuxiang Fang (1 shared paper)
In The Last Decade
Chaping Cheng
18 papers receiving 676 citations
Chaping Cheng's Hit Papers
Peers
Comparison fields: 5 of 64
- Cancer Research 131
- Pulmonary and Respiratory Medicine 191
- Oncology 126
- Molecular Biology 235
- Immunology 58
Countries citing papers authored by Chaping Cheng
This map shows the geographic impact of Chaping Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaping Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaping Cheng more than expected).
Fields of papers citing papers by Chaping Cheng
This network shows the impact of papers produced by Chaping Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaping Cheng. The network helps show where Chaping Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaping Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 120 | |
| 2 | Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation Hit paper breakdown → | 2023 | 113 |
| 3 | 2022 | 53 | |
| 4 | 2018 | 50 | |
| 5 | 2020 | 49 | |
| 6 | 2024 | 42 | |
| 7 | 2017 | 39 | |
| 8 | 2019 | 39 | |
| 9 | 2018 | 35 | |
| 10 | 2023 | 33 | |
| 11 | 2025 | 28 | |
| 12 | 2023 | 23 | |
| 13 | 2024 | 19 | |
| 14 | 2021 | 17 | |
| 15 | 2019 | 15 | |
| 16 | 2025 | 2 | |
| 17 | 2026 | 2 | |
| 18 | 2025 | 1 |
About Chaping Cheng
Chaping Cheng is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Oncology, Hematology and Cancer Research, having authored 18 papers that have together received 680 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (10 papers), Cancer Cells and Metastasis (3 papers), Immune cells in cancer (2 papers), Ferroptosis and cancer prognosis (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Microtubule and mitosis dynamics (1 paper) and Genomics and Chromatin Dynamics (1 paper). The work is most often cited by research in Cancer Research (131 citations), Pulmonary and Respiratory Medicine (191 citations), Oncology (126 citations), Molecular Biology (235 citations) and Immunology (58 citations). Chaping Cheng has collaborated with scholars based in China, Hong Kong and Sweden. Frequent co-authors include Wei‐Qiang Gao, Helen He Zhu, Zhongzhong Ji, Xue Wang, Huifang Zhao, Yanjing Guo, Li Li, Yuxiang Fang, Dawei Xu and Kai Zhang. Their work appears in journals such as Nature Communications, Journal of Clinical Investigation, Cell Proliferation, Advanced Science and Nature Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.